Identification of potent anticancer copper(II) complexes containing tripodal bis[2-ethyl-di(3,5- dialkyl-1H-pyrazol-1-yl)]amine moiety
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15640%2F21%3A73609061" target="_blank" >RIV/61989592:15640/21:73609061 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61989592:15310/21:73609061
Výsledek na webu
<a href="https://pubs.rsc.org/en/content/articlelanding/2021/DT/D1DT01724A" target="_blank" >https://pubs.rsc.org/en/content/articlelanding/2021/DT/D1DT01724A</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/d1dt01724a" target="_blank" >10.1039/d1dt01724a</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Identification of potent anticancer copper(II) complexes containing tripodal bis[2-ethyl-di(3,5- dialkyl-1H-pyrazol-1-yl)]amine moiety
Popis výsledku v původním jazyce
A series of heteroleptic copper(II) complexes of the composition [Cu(L1-5)Cl]X, where X = ClO4 and/or PF6 and [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl))-(6-methyl-(2-pyridylmethyl))]amine (L-1), (bis(2-ethyl-d i (3,5-dimethyl-1H-pyrazol-1-yl))-(3,4-dimethoxy-(2-pyridylmethyl))]amine (L-2), [bis(2-ethyl-di (3,5-dimethyl-1H-pyrazol-1-yl)-(2-quinolymethyl)]amine (L-3), [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazolyl)-(di(3,5-dimethyl-1H-pyrazol-1-yl-methyl))]amine (L-4) and [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl)-(5-methyl-3-phenyl-1H-pyrazol-1-yl-methyl)]amine (L-5), were prepared and thoroughly characterized including single-crystal X-ray diffraction technique. The in vitro cytotoxicity of complexes against A2780, A2780R, HOS and MCF-7 human cancer cell lines was evaluated using the MTT test. The results revealed that complexes [Cu(L-1)Cl]PF6 (1-PF6), [Cu(L-2)Cl]ClO4 (2-ClO4) and [Cu(L-3)Cl]PF6 (3-PF6) are the most effective, with IC50 values ranging from 1.4 to 6.3 mu M, thus exceeding the cytotoxic potential of metallodrug cisplatin (IC50 values ranging from 29.9 to 82.0 mu M). The complexes [Cu(L-4)Cl]PF6 (4-PF6) and [Cu(L-5)Cl]PF6 (5-PF6 ) showed only moderate cytotoxicity against A2780, with IC50 = 53.6 mu M, and 33.8 mu M, respectively. The cell cycle profile, time-resolved cellular uptake, interactions with small sulfur-containing biomolecules (cysteine and glutathione), intracellular ROS production, induction of apoptosis and activation of caspases 3/7 were also evaluated in the case of the selected complexes. It has been found that the best performing complexes 1 and 2 cause cell arrest in the G2/M phase and induce apoptosis via the increase in production of ROS, dominantly due to the overproduction of superoxide.
Název v anglickém jazyce
Identification of potent anticancer copper(II) complexes containing tripodal bis[2-ethyl-di(3,5- dialkyl-1H-pyrazol-1-yl)]amine moiety
Popis výsledku anglicky
A series of heteroleptic copper(II) complexes of the composition [Cu(L1-5)Cl]X, where X = ClO4 and/or PF6 and [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl))-(6-methyl-(2-pyridylmethyl))]amine (L-1), (bis(2-ethyl-d i (3,5-dimethyl-1H-pyrazol-1-yl))-(3,4-dimethoxy-(2-pyridylmethyl))]amine (L-2), [bis(2-ethyl-di (3,5-dimethyl-1H-pyrazol-1-yl)-(2-quinolymethyl)]amine (L-3), [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazolyl)-(di(3,5-dimethyl-1H-pyrazol-1-yl-methyl))]amine (L-4) and [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl)-(5-methyl-3-phenyl-1H-pyrazol-1-yl-methyl)]amine (L-5), were prepared and thoroughly characterized including single-crystal X-ray diffraction technique. The in vitro cytotoxicity of complexes against A2780, A2780R, HOS and MCF-7 human cancer cell lines was evaluated using the MTT test. The results revealed that complexes [Cu(L-1)Cl]PF6 (1-PF6), [Cu(L-2)Cl]ClO4 (2-ClO4) and [Cu(L-3)Cl]PF6 (3-PF6) are the most effective, with IC50 values ranging from 1.4 to 6.3 mu M, thus exceeding the cytotoxic potential of metallodrug cisplatin (IC50 values ranging from 29.9 to 82.0 mu M). The complexes [Cu(L-4)Cl]PF6 (4-PF6) and [Cu(L-5)Cl]PF6 (5-PF6 ) showed only moderate cytotoxicity against A2780, with IC50 = 53.6 mu M, and 33.8 mu M, respectively. The cell cycle profile, time-resolved cellular uptake, interactions with small sulfur-containing biomolecules (cysteine and glutathione), intracellular ROS production, induction of apoptosis and activation of caspases 3/7 were also evaluated in the case of the selected complexes. It has been found that the best performing complexes 1 and 2 cause cell arrest in the G2/M phase and induce apoptosis via the increase in production of ROS, dominantly due to the overproduction of superoxide.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10402 - Inorganic and nuclear chemistry
Návaznosti výsledku
Projekt
<a href="/cs/project/EF16_019%2F0000754" target="_blank" >EF16_019/0000754: Nanotechnologie pro budoucnost</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Dalton Transactions
ISSN
1477-9226
e-ISSN
—
Svazek periodika
50
Číslo periodika v rámci svazku
33
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
14
Strana od-do
11521-11534
Kód UT WoS článku
000680877300001
EID výsledku v databázi Scopus
2-s2.0-85113706204